JNJ vs ORMP: Which Is the Better Dividend Stock?
As of Nov 8, 2026, JNJ and ORMP are closely matched. ORMP offers the higher yield at 6.48%, JNJ has the higher dividend-safety score, and ORMP looks like the better value (its fair-value estimate is 33% below its share price).
Key facts: JNJ vs ORMP
Data as of · Source: SmarterDividends data
- As of Nov 8, 2026, Oramed Pharmaceuticals Inc. (ORMP) has the higher forward dividend yield at 6.48%, versus 1.94% for Johnson & Johnson (JNJ).
- By SmarterDividends' count as of Nov 8, 2026, JNJ has raised its dividend for 55 consecutive years and ORMP for 0.
- As of Nov 8, 2026, JNJ pays out 80% of its earnings as dividends and ORMP pays out 6%.
- As of Nov 8, 2026, JNJ's fair-value estimate is 54% below its share price and ORMP's fair-value estimate is 33% below its share price, so ORMP looks like the better value of the two on SmarterDividends' blended model.
Cite this page
SmarterDividends, "JNJ vs ORMP: Dividend Yield, Safety & Value Compared," updated Nov 8, 2026, https://smarterdividends.com/compare/jnj-vs-ormp
| Metric | JNJ | ORMP |
|---|---|---|
| Forward yield | 1.94% | 6.48% |
| Annual dividend | $5.36 | $0.25 |
| Payout ratio | 80% | 6% |
| Years of growth | 55 yr | 0 yr |
| 5-yr dividend growth | 5.2% | — |
| 5-yr total return | 77% | -80% |
| Dividend safety score | 93 (A) | — |
| Fair value estimate | $126.72 | $2.59 |
| Upside to fair value | -54% | -33% |
| Frequency | quarterly | annual |
| Market cap | $664.9B | $160.6M |
| P/E ratio | 41.9 | 0.9 |
Higher yield
ORMP
6.48%
Safer dividend
JNJ
Grade A
Faster growth
JNJ
5.2%
Better value
ORMP
-33% upside
JNJ vs ORMP — FAQ
Is JNJ or ORMP a better dividend stock?
JNJ and ORMP are closely matched. ORMP has the higher yield; JNJ scores better on safety.
Which has a higher dividend yield, JNJ or ORMP?
ORMP has the higher forward dividend yield at 6.48%, versus 1.94% for JNJ.
Is JNJ or ORMP safer?
Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.
Is JNJ or ORMP better value right now?
As of Nov 8, 2026, ORMP looks like the better value: its fair-value estimate is 33% below its share price (overvalued). For JNJ, its fair-value estimate is 54% below its share price.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.